title: Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival.
abstract: Cardiac amyloidosis has a poor prognosis, with a median survival of approximately 6 months once symptoms develop. This patient had a markedly improved quality of life with cardiac transplantation. We would suggest that with refinement of pretransplant chemotherapy, prolonged survival may be possible in carefully selected cases.
authors.affiliation: Division of Cardiology, Boston University School of Medicine, Massachusetts 02118, USA.
authors.forename: S
authors.initials: S
authors.lastname: Dubrey
authors.forename: R W
authors.initials: RW
authors.lastname: Simms
authors.forename: M
authors.initials: M
authors.lastname: Skinner
authors.forename: R H
authors.initials: RH
authors.lastname: Falk
mesh_terms: D000686:Amyloidosis / Q000000981:diagnostic imaging / Q000601:surgery*; D009202:Cardiomyopathies / Q000000981:diagnostic imaging / Q000601:surgery*; D004452:Echocardiography; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D008875:Middle Aged; D012008:Recurrence; D017741:Survivors